All Stories

  1. Bleeding localized amyloidosis of the colon
  2. The Novel Role of HtrA1 in Gingivitis, Chronic and Aggressive Periodontitis
  3. m-TOR inhibitors may be useful in the treatment of encapsulating peritoneal sclerosis (EPS)
  4. p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival
  5. Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes
  6. Microvessel density and VEGF, HIF‐1α expression in primary oral melanoma: correlation with prognosis
  7. Immunohistochemical correlation between microvessel density and lymphoid infiltrate in radicular cysts
  8. Familial haemophagocytic lymphohistiocytosis-related plasma cell neoplasm: a case report
  9. Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds
  10. Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease‐free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy
  11. Doxycycline-isoniazid: a new therapeutic association for recalcitrant acne agminata
  12. Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas
  13. Hemangioma in POEMS syndrome: an atypical clinical and histological presentation
  14. Histological description of the lymphadenopathy related to Toscana virus infection. Report of a case
  15. Chryseomonas luteola: an unusual clinical infection mimicking a mediastinal malignant lymphoma
  16. Clinical, power Doppler sonography and histological assessment of the psoriatic plaque: short-term monitoring in patients treated with etanercept
  17. Immunohistochemical expression of vascular endothelial growth factor (VEGF) in different types of odontogenic cysts
  18. Proangiogenetic molecules, hypoxia-inducible factor-1α and nitric oxide synthase isoforms in ovarian endometriotic cysts
  19. Normolipemic plane xanthomatosis with acute development preceding the clinical onset of rheumatoid arthritis
  20. Gingival vascular damage in atherosclerotic rabbits: Hydroxytyrosol and squalene benefits
  21. VEGF, survivin and NOS overexpression in psoriatic skin: Critical role of nitric oxide synthases
  22. Diffuse large B-cell lymphoma with Homer-Wright rosettes, sinusoidal growth pattern, and CD30 expression: A possible overlap between microvillous lymphomas and sinusoidal CD30-positive large B-cell lymphomas
  23. Expression of Vascular Endothelial Growth Factor (VEGF), Hypoxia Inducible Factor-1α (HIF-1α), and Microvessel Density in Endometrial Tissue in Women With Adenomyosis
  24. Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B‐cell lymphomas and comparison with the commonly used therapies
  25. Expression of Transforming Growth Factor β1 in Ameloblastomas
  26. RNAIII-Inhibiting Peptide Enhances Healing of Wounds Infected with Methicillin-Resistant Staphylococcus aureus
  27. Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model
  28. CD10 expression in stromal cells of ameloblastoma variants
  29. S100A8 calcium-binding expression in radicular and dentigerous cysts and in keratocystic odontogenic tumors
  30. Comparative Efficacy of Topical Versus Systemic Teicoplanin in Experimental Model of Wound Infections
  31. CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept
  32. Maspin Expression in Oral Squamous Cell Carcinoma
  33. Coexistence of two discordant B-cell lymphomas in the skin and lymph node: report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma
  34. Differences in survivin location and Bcl-2 expression in CD30+ lymphoproliferative disorders of the skin compared with systemic anaplastic large cell lymphomas: an immunohistochemical study
  35. Oral lichen planus treated with 13-cis-retinoic acid (isotretinoin): effects on the apoptotic process
  36. Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas
  37. Nifedipine and Cyclosporin Affect Fibroblast Calcium and Gingiva
  38. KAI-1 Protein Expression in Odontogenic Cysts
  39. Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: No evidence ofBorrelia burgdorferiassociation
  40. Expression of motility-related molecule Cdc42 in endometrial tissue in women with adenomyosis and ovarian endometriomata
  41. The role of dendritic cells and T lymphocytes in human melanoma: an immunohistochemical study
  42. Severe diarrhoea during Campath-1H treatment for refractory cutaneous T-cell lymphoma
  43. Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape
  44. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions
  45. Myeloid sarcoma of the maxillary bone
  46. The biocompatibility of dibutyryl chitin in the context of wound dressings
  47. Recurrent epithelioid angiosarcoma of the scalp simulating melanoma. A 10‐year follow‐up
  48. Long‐term experience with low‐dose interferon‐α and PUVA in the management of early mycosis fungoides
  49. Immunohistochemical expression of DNA mismatch repair (MMR) system proteins (hMLH1, hMSH2) in cervical preinvasive and invasive lesions
  50. Immunohistochemical analysis of soft tissues in implants with healthy and peri‐implantitis condition, and aggressive periodontitis
  51. Cutaneous Kikuchi's disease: report of a new case and review of the literature
  52. Mycobacterium lentiflavum as an Emerging Causative Agent of Cervical Lymphadenitis
  53. Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata
  54. Micronodular T-cell/Histiocyte-Rich Large B-cell Lymphoma of the Spleen
  55. Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides
  56. Central granular cell odontogenic tumour: report of the first malignant case and review of the literature
  57. A Case of Follicular Mycosis Fungoides With Follicular Mucinosis
  58. A clinicopathological study of 152 surgically treated primary gastric lymphomas with survival analysis of 109 high grade tumours
  59. Bone Marrow Extracellular Large Geometric Crystals in IgG/λ MGUS
  60. Cutaneous carcinomas and preinvasive neoplastic lesions. Role of MMP‐2 and MMP‐9 metalloproteinases in neoplastic invasion and their relationship with proliferative activity and p53 expression
  61. Adult Rhabdomyoma: Report of Two Cases of Rhabdomyoma of the Lip and of the Eyelid
  62. MIB 1 Immunostaining in Cervical Carcinoma of Young Patients
  63. Localized amyloidosis and gastrointestinal lymphoma: a rare association
  64. The role of human papillomavirus DNAs in cervical carcinoma and risk of lymph node metastasis
  65. MIB 1 Immunostaining in Cervical Carcinoma of Young Patients
  66. Synchronous Mucosa-Associated Lymphoid Tissue Lymphoma and Adenocarcinoma of the Stomach
  67. Microinvasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia: Biologic Significance and Clinical Implications of 72-kDa Metalloproteinase Immunostaining
  68. Epithelioid haemangioma of the heart
  69. Proliferating cell nuclear antigen (PCNA) immunoreactivity in stage I endometrial carcinoma: a new prognostic factor
  70. Proliferating Cell Nuclear Antigen in Endometrial Carcinoma: Pretreatment Identification of High-Risk Patients
  71. Recurrence Patterns in Locally Advanced Cervical Carcinoma: Role of Nodal Status and 72-kDa Metalloproteinase Index
  72. 72-KiloDalton Type IV Collagenase, Type IV Collagen, and Ki 67 Antigen in Serous Tumors of the Ovary
  73. The 72-kDa Metalloproteinase Immunostaining in Cervical Carcinoma: Relationship with Lymph Nodal Involvement
  74. MIB 1 lmmunostaining in Cervical Intraepithelial Neoplasia: Prognostic Significance in Mild and Moderate Lesions
  75. Modulation of expression of p53 and cell proliferation in locally advanced cervical carcinoma after neoadjuvant combination chemotherapy
  76. Nodal immune reactivity in FIGO Stage I endometrial carcinoma: relationship with myometrial invasion
  77. Elastofibrolipoma of the Mediastinum
  78. Ki67 Antigen Immunostaining (MIB 1 Monoclonal Antibody) in Serous Ovarian Tumors: Index of Proliferative Activity with Prognostic Significance
  79. Natural Killer Cell Activity in Patients with Invasive Cervical Carcinoma: Importance of a Longitudinal Evaluation in Follow-Up
  80. HPV DNA Positivity and Natural Killer Cell Activity in the Clinical Outcome of Mild Cervical Dysplasia: Integration between Virus and Immune System
  81. Natural Killer Cell Activity in Stage I Endometrial Carcinoma: Correlation with Nuclear Grading, Myometrial Invasion, and Immunoreactivity of Proliferating Cell Nuclear Antigen
  82. Centrocytic-like lymphoma associated with localized amyloidosis of the large intestine
  83. The relationshp of clinical‐pathologic status and adiuvant treatment with natural hller cell activity in stage I and II endometrial carcinoma
  84. Interferon Alpha 2b Treatment of Cervical Intraepithelial Neoplasia Grade 2: Modulation of Natural Killer Cell
  85. Vaginal Micropapillary Lesions Are Not Related to Human Papillomavirus Infection: In situ Hybridization and Polymerase Chain Reaction Detection Techniques
  86. Lipid-rich Adenoma of the Thyroid